Company Presentation • 28 Jul 2025 20:00
Company Presentation • 31 Jan 2025 20:00
Company Presentation • 11 Mar 2025 20:00
Company Presentation • 05 Apr 2025 19:00
Company Presentation • 25 Jun 2025 19:00
Search or
𝛼SK
𝛼SKENTITY
CervoMed (CRVO US)
CervoMed (CRVO US)
2
Analysis
Health Care • United States
Cervomed Inc. operates as a clinical stage biotechnology company. The Company develops and commercializes drug treatments for dementia with lewy bodies, alzheimer's disease, and other central nervous system disorders. CervoMed serves patients in the United States.
morex